CYTYC Message Board - Msg: 428985

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTYC

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Zwiener who wrote (2)	11/8/1996 8:52:00 AM
From: Chris Spychalski	of 79

That's right! Additionally, the agreement w/Digene (DIGE) allows mutliple uses (HPV test) for the sample (now preserved due to CYTC proprietary technology). This strengthens the lock on the market. This stock was trading at 30+ this summer (when the market sucked for biotech). CEO Pat Sullivan stated that earning expectations for 4th Q are roughly similar to 3rd. Significant product (ThinPrepTM) rollout for 1/97 should boost earnings, IMHO, because once a machine is in place, reagents and supplies have the best margins in this biz. What's your assesment of the competition? Could you ask the gyn's what they think? Your previous postings look like you're a valuable contributor to SI. Chris

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next